NAT COMMUN:线粒体控制伤口愈合和肿瘤生长过程中的血管生成

2020-07-22 MedSci原创 MedSci原创

血管是一个高度可塑性的组织,在血管生成过程中能够从静止状态切换到活跃的增殖状态。在此过程中,内皮细胞(ECs)的代谢重编程是至关重要的,以满足生长条件下不断增加的细胞能量需求。

血管是一个高度可塑性的组织,在血管生成过程中能够从静止状态切换到活跃的增殖状态。在此过程中,内皮细胞(ECs)的代谢重编程是至关重要的,以满足生长条件下不断增加的细胞能量需求。

在这里,研究人员评估了线粒体生物能对新生血管的影响,其通过在小鼠ECs中特异性地删除编码细胞色素c氧化酶(COX)组装因子cox10的基因,为血管受限性呼吸不足提供了一个模型。

研究人员表明,EC特异性cox10敲除导致血管发育缺陷,造成胚胎致死。在成年小鼠中,诱导EC特异性cox10基因缺失不会产生明显的表型。然而,在有能量需求的情况下,COX缺失的ECs的血管生成能力是严重受损的,表现出显著延迟的伤口愈合和受损的肿瘤生长。

总之,本研究为新血管生成时,血管内皮细胞在发育、组织修复和癌症过程中对线粒体呼吸的需求提供了遗传证据。

 

原始出处:

L. M. Schiffmann et al. Mitochondrial respiration controls neoangiogenesis during wound healing and tumour growth, Nature Communications (2020). 

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1884474, encodeId=df5518844e4be, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Mar 08 18:51:32 CST 2021, time=2021-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809306, encodeId=809980930613, content=学习了!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Aug 16 09:02:07 CST 2020, time=2020-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2087718, encodeId=e569208e71844, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Wed Feb 24 14:51:32 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309906, encodeId=8509130990624, content=<a href='/topic/show?id=5e6926003ae' target=_blank style='color:#2F92EE;'>#伤口愈合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26003, encryptionId=5e6926003ae, topicName=伤口愈合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Fri Jul 24 01:51:32 CST 2020, time=2020-07-24, status=1, ipAttribution=)]
    2021-03-08 liye789132251
  2. [GetPortalCommentsPageByObjectIdResponse(id=1884474, encodeId=df5518844e4be, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Mar 08 18:51:32 CST 2021, time=2021-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809306, encodeId=809980930613, content=学习了!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Aug 16 09:02:07 CST 2020, time=2020-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2087718, encodeId=e569208e71844, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Wed Feb 24 14:51:32 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309906, encodeId=8509130990624, content=<a href='/topic/show?id=5e6926003ae' target=_blank style='color:#2F92EE;'>#伤口愈合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26003, encryptionId=5e6926003ae, topicName=伤口愈合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Fri Jul 24 01:51:32 CST 2020, time=2020-07-24, status=1, ipAttribution=)]
    2020-08-16 大爰

    学习了!!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1884474, encodeId=df5518844e4be, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Mar 08 18:51:32 CST 2021, time=2021-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809306, encodeId=809980930613, content=学习了!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Aug 16 09:02:07 CST 2020, time=2020-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2087718, encodeId=e569208e71844, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Wed Feb 24 14:51:32 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309906, encodeId=8509130990624, content=<a href='/topic/show?id=5e6926003ae' target=_blank style='color:#2F92EE;'>#伤口愈合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26003, encryptionId=5e6926003ae, topicName=伤口愈合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Fri Jul 24 01:51:32 CST 2020, time=2020-07-24, status=1, ipAttribution=)]
    2021-02-24 liuli5079
  4. [GetPortalCommentsPageByObjectIdResponse(id=1884474, encodeId=df5518844e4be, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Mon Mar 08 18:51:32 CST 2021, time=2021-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809306, encodeId=809980930613, content=学习了!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Sun Aug 16 09:02:07 CST 2020, time=2020-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2087718, encodeId=e569208e71844, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Wed Feb 24 14:51:32 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309906, encodeId=8509130990624, content=<a href='/topic/show?id=5e6926003ae' target=_blank style='color:#2F92EE;'>#伤口愈合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26003, encryptionId=5e6926003ae, topicName=伤口愈合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Fri Jul 24 01:51:32 CST 2020, time=2020-07-24, status=1, ipAttribution=)]

相关资讯

人到中年怕突然生病,而这个罕见的肿瘤“偏爱”中年人

人到中年,往往上有老人,下有稚子,身边有伴侣,此时最怕生病。而这正是41岁老刘的真实写照。

全新《CSCO原发性肝癌诊疗指南》发布 多种策略促规范化治疗

秦叔逵认为,肝癌治疗目前正面临着极大的未被满足的需求。 陈静 摄

综述:盘点2020年单细胞测序研究——肿瘤篇

单细胞测序技术自 2009 年问世,2013 年被 Nature Methods 评为年度技术以来,越来越多地被应用在基础科研和临床研究等方面。

SCI SIGNAL:氧化磷酸化缺陷的癌细胞靠什么存活?

抑制ER到mitochondria的Ca2+转移可能是一种针对癌细胞的通用治疗策略,无论其OXPHOS状态如何。

NSR:清华大学朱永法等团队开发新方法:10分钟内消除肿瘤,50天内小鼠存活率从0上升到100%

光催化治疗后50天小鼠存活率从0%增加到100%。基于卟啉的光催化剂由于尺寸选择作用可以被癌细胞靶向地内化而不进入正常细胞。

Nature:线粒体泛醌氧化是肿瘤生长的必要条件

线粒体电子传递链(ETC)对于肿瘤生长是必不可少的,与靶向治疗相结合,ETC的抑制已经被证明有抗肿瘤疗效。此外,人类大脑和肺部肿瘤线粒体具有强大的葡萄糖氧化能力。